MOSCOW (MRC) -- Arkema's Q1 2014 sales stood at EUR1,523 million against EUR1,563 million in 1st quarter 2013, as per the company's financial report.
Volumes grew by 3.3% compared to 1st quarter 2013, sustained by more favourable market conditions than at the beginning of 2013 in High Performance Materials and by solid volumes in the Coating Solutions segment.
The -2.6% price effect essentially reflects lower prices and an unfavourable product mix in fluorogases. The currency translation
effect, mostly related to the weakening of the US dollar compared to the euro, amounted to -2.1%. The -1.2% scope of business effect reflects the deconsolidation of the coating resins companies in South Africa currently being divested and the change in the consolidation method for certain joint ventures.
EBITDA reached EUR213 million (EUR234 million in 1st quarter 2013) and EBITDA margin stood at 14%. A strong increase in volumes combined with productivity efforts and a strict control of fixed costs helped mitigate the impact, in fluorogases, of lower unit margins and an unfavorable product mix compared to the very high basis of comparison last year, as well as the strength of the euro compared to the US dollar.
In 1st quarter 2014, Arkema generated EUR83 million free cash flow against EUR100 million in 1st quarter 2013. It mostly reflects the traditional seasonality of working capital related to the increase in sales compared to year-
end, and includes capital expenditure totalling EUR90 million, of which EUR45 million exceptional capital expenditure
related to the construction of the thiochemicals platform in Malaysia and the finalisation of the investment programme in Lacq (France) as part of the site’s securing of sulphur feedstock for the next 30 years.
The group’s capital expenditure should amount to EUR450 million for the full year. Net debt stood at EUR1,007 million at 31 March 2014, stable compared to 31 March 2013 (EUR1,009 million). Gearing remained well under control at 42%.
"The 1st quarter performance is underpinned by growth in volumes. As anticipated, performance in fluorogases was significantly down compared to the high reference point of last year. Excluding fluorogases, the Group’s EBITDA improved noticeably despite an unfavourable euro/US dollar exchange rate.
High Performance Materials achieved very good results in market conditions that had improved over last year, and benefited from the group’s innovation drive.
The results of Industrial Specialties were affected by the specific situation in fluorogases, but showed a slight improvement overall in the other product lines.
The Coating Solutions segment has shown, quarter after quarter, its ability to adapt to mixed environments. This performance reflects the productivity efforts that have been ongoing for the past two years, as well as the relevance of the investment projects undertaken in this segment, in particular in North America."
As MRC reported before, in early 2014, Arkema announced the construction of a new organic peroxide plant on its Changshu site in China. This investment will help double the site’s production capacity. By doubling its production capacity in China, Arkema will continue to support the strong growth in the organic peroxide market in Asia, a region in which the Group is also a producer in India, South Korea and Japan. The new Changshu plant is due to come on stream in early 2016.
Arkema with annual revenue of EUR6.1 billion is a leading European supplier of chlorochemicals and PVC. Kynar and Kynar Flex are registered trademarks of Arkema Inc. Arkema operates 11 organic peroxide plants on the three continents, has operations in more than 40 countries, some 14,000 employees and 10 research centers.
MRC